Myeloid-derived suppressor cells in transplantation: the dawn of cell therapy

J Transl Med. 2018 Jan 29;16(1):19. doi: 10.1186/s12967-018-1395-9.

Abstract

Myeloid-derived suppressor cells (MDSCs) are a series of innate cells that play a significant role in inhibiting T cell-related responses. This heterogeneous population of immature cells is involved in tumor immunity. Recently, the function and importance of MDSCs in transplantation have garnered the attention of scientists and have become an important focus of transplantation immunology research because MDSCs play a key role in establishing immune tolerance in transplantation. In this review, we summarize recent studies of MDSCs in different types of transplantation. We also focus on the influence of immunosuppressive drugs on MDSCs as well as future obstacles and research directions in this field.

Keywords: Cell therapy; Immunology; Myeloid-derived suppressor cell (MDSC); Regulation; Transplantation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cell- and Tissue-Based Therapy*
  • Humans
  • Immune Tolerance / drug effects
  • Immunosuppressive Agents / pharmacology
  • Myeloid-Derived Suppressor Cells / cytology
  • Myeloid-Derived Suppressor Cells / drug effects
  • Myeloid-Derived Suppressor Cells / transplantation*
  • Transplantation

Substances

  • Immunosuppressive Agents